• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B型血友病携带者状态的实验室预测:检测方法重复性的作用。

Laboratory prediction of the carrier state in hemophilia B: role of replication of assays.

作者信息

Lipworth L, Tiarks C Y, Rice C A, Pechet L

出版信息

Am J Clin Pathol. 1979 Dec;72(6):1000-4. doi: 10.1093/ajcp/72.6.1000.

DOI:10.1093/ajcp/72.6.1000
PMID:391020
Abstract

The authors studied the effect of averaging replicated assays of Factor IX coagulation activity and Factor IX antigen on each plasma specimen in improving the ability to detect carriers of hemophilia B. The improvement resulting from this procedure is particularly marked in tests depending on the linear regression of one characteristic on another to diagnose the carrier state. The effects of averaging assays on the ratio of Factor IX coagulation activity to Factor IX antigen were also explored. The benefits of averaging replications were not greatly increased by use of more than four replications.

摘要

作者研究了对每份血浆标本的凝血因子IX活性和凝血因子IX抗原的重复检测结果进行平均,对提高检测B型血友病携带者能力的影响。在依靠一种特性对另一种特性进行线性回归来诊断携带者状态的检测中,这一程序带来的改善尤为显著。还探讨了检测结果平均化对凝血因子IX活性与凝血因子IX抗原比值的影响。重复检测超过四次后,平均化检测带来的益处并未大幅增加。

相似文献

1
Laboratory prediction of the carrier state in hemophilia B: role of replication of assays.B型血友病携带者状态的实验室预测:检测方法重复性的作用。
Am J Clin Pathol. 1979 Dec;72(6):1000-4. doi: 10.1093/ajcp/72.6.1000.
2
Detection of carriers of haemophilia B.乙型血友病携带者的检测
Br J Haematol. 1979 Jun;42(2):293-301. doi: 10.1111/j.1365-2141.1979.tb01133.x.
3
[Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].[B型血友病变体及B型血友病携带者中无活性因子IX的存在情况]
Minerva Med. 1975 Jun 9;66(42):2037-43.
4
Oral contraception and the detection of carriers in haemophilia B.口服避孕药与B型血友病携带者的检测
Thromb Res. 1978 Sep;13(3):379-88. doi: 10.1016/0049-3848(78)90124-x.
5
An immunological method for detection of the carrier of hemophilia B.一种检测乙型血友病携带者的免疫学方法。
Thromb Haemost. 1976 Nov 30;36(2):441-50.
6
An agarose plate method for detecting alloantisera to coagulant factor IX and factor IX antigen.一种检测凝血因子IX同种异体抗血清和因子IX抗原的琼脂糖平板法。
Br J Haematol. 1980 Feb;44(2):313-21. doi: 10.1111/j.1365-2141.1980.tb01214.x.
7
Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX.
Blood. 1980 Sep;56(3):397-401.
8
Two allotypes of factor IX present in haemophilia B.血友病B中存在两种凝血因子IX同种异型。
Scand J Haematol. 1986 Nov;37(5):411-6. doi: 10.1111/j.1600-0609.1986.tb02629.x.
9
[Behavior of the coagulation factor IX following intravenous application of Tralysol in persons with Hematophilia B].[血友病B患者静脉注射曲拉西醇后凝血因子IX的行为]
Klin Wochenschr. 1970 May 15;48(10):632-4. doi: 10.1007/BF01485399.
10
Characterization of heterogeneity of haemophilia B for the detection of carriers.用于携带者检测的B型血友病异质性特征分析
Haemostasis. 1980;9(5):310-8. doi: 10.1159/000214370.